MX2019008970A - Ensayos de socio de unión específico de plasmón basados en solución y nanoestructuras metálicas. - Google Patents

Ensayos de socio de unión específico de plasmón basados en solución y nanoestructuras metálicas.

Info

Publication number
MX2019008970A
MX2019008970A MX2019008970A MX2019008970A MX2019008970A MX 2019008970 A MX2019008970 A MX 2019008970A MX 2019008970 A MX2019008970 A MX 2019008970A MX 2019008970 A MX2019008970 A MX 2019008970A MX 2019008970 A MX2019008970 A MX 2019008970A
Authority
MX
Mexico
Prior art keywords
solution
sample
detection
specific
binding partner
Prior art date
Application number
MX2019008970A
Other languages
English (en)
Spanish (es)
Inventor
K Mehra Rajesh
P Aron Kenneth
CHIANG Vincent
Ann Unser Sarah
Original Assignee
Abay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abay Sa filed Critical Abay Sa
Publication of MX2019008970A publication Critical patent/MX2019008970A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/55Specular reflectivity
    • G01N21/552Attenuated total reflection
    • G01N21/553Attenuated total reflection and using surface plasmons
    • G01N21/554Attenuated total reflection and using surface plasmons detecting the surface plasmon resonance of nanostructured metals, e.g. localised surface plasmon resonance
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346Nanoparticles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553Metal or metal coated
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/10Detection of antigens from microorganism in sample from host
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MX2019008970A 2017-01-30 2018-01-30 Ensayos de socio de unión específico de plasmón basados en solución y nanoestructuras metálicas. MX2019008970A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762451932P 2017-01-30 2017-01-30
PCT/US2018/015981 WO2018140953A1 (en) 2017-01-30 2018-01-30 Solution-based plasmon specific-binding partner assays and metallic nanostructures

Publications (1)

Publication Number Publication Date
MX2019008970A true MX2019008970A (es) 2019-12-19

Family

ID=62978809

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2019008970A MX2019008970A (es) 2017-01-30 2018-01-30 Ensayos de socio de unión específico de plasmón basados en solución y nanoestructuras metálicas.
MX2023012379A MX2023012379A (es) 2017-01-30 2019-07-29 Ensayos de socio de union especifico de plasmon basados en solucion y nanoestructuras metalicas.
MX2023002376A MX2023002376A (es) 2017-01-30 2019-07-29 Ensayos de socio de union especifico de plasmon basados en solucion y nanoestructuras metalicas.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2023012379A MX2023012379A (es) 2017-01-30 2019-07-29 Ensayos de socio de union especifico de plasmon basados en solucion y nanoestructuras metalicas.
MX2023002376A MX2023002376A (es) 2017-01-30 2019-07-29 Ensayos de socio de union especifico de plasmon basados en solucion y nanoestructuras metalicas.

Country Status (11)

Country Link
US (2) US11977072B2 (https=)
EP (1) EP3574308A4 (https=)
JP (2) JP7308148B2 (https=)
KR (3) KR102486615B1 (https=)
CN (3) CN118275398A (https=)
AU (2) AU2018212009B2 (https=)
CA (1) CA3051465A1 (https=)
IL (2) IL268238B (https=)
MX (3) MX2019008970A (https=)
NZ (1) NZ796662A (https=)
WO (1) WO2018140953A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3489685T (pt) 2011-11-21 2024-01-04 Zoetis Services Llc Amplificação de sinais em imunoensaios de fluxo lateral e relacionados
TWI691716B (zh) 2014-08-13 2020-04-21 美商艾巴希斯公司 電漿特異性結合搭配物檢定中之信號放大
EP4465021A3 (en) 2015-08-04 2025-02-26 Zoetis Services LLC Signal amplification in solution-based plasmonic specific-binding partner assays
US11299777B2 (en) 2016-04-04 2022-04-12 Nat Diagnostics, Inc. Isothermal amplification components and processes
US9617587B1 (en) 2016-04-04 2017-04-11 Nat Diagnostics, Inc. Isothermal amplification components and processes
WO2018140953A1 (en) 2017-01-30 2018-08-02 Abaxis, Inc. Solution-based plasmon specific-binding partner assays and metallic nanostructures
EP3873977A4 (en) * 2018-11-01 2022-07-13 NB Postech Nitrocellulose membrane comprising non-covalently attached organic nanostructured molecule
GB2590485B (en) * 2019-12-19 2022-04-13 Vidya Holdings Ltd Nanoparticle conjugation
US11609229B2 (en) 2020-04-30 2023-03-21 Mytech Co. Ltd. Fluorescence counting system for quantifying viruses or antibodies on an immobilized metal substrate by using an antigen-antibody reaction
JP7589532B2 (ja) * 2020-12-14 2024-11-26 日油株式会社 イムノクロマト測定法用増感剤及び測定法
CA3215851A1 (en) * 2021-04-21 2022-10-27 Udayan Kanade System and method for simulating a localized surface plasmon resonance (lspr) spectrometer
CN114480591B (zh) * 2022-03-09 2022-11-08 武汉爱博泰克生物科技有限公司 一种用于一步法qpcr试剂的冻干保护剂及其应用
WO2023224100A1 (ja) * 2022-05-18 2023-11-23 公立大学法人大阪 糖タンパク質を検出するためのキット
WO2024075847A1 (ja) * 2022-10-06 2024-04-11 積水メディカル株式会社 非特異反応抑制剤、非特異反応抑制剤の使用方法、非特異反応抑制方法、生化学的測定用試薬、検体前処理液、及び生化学的測定用試薬キット
CN116183901B (zh) * 2023-01-04 2025-04-18 烟台大学 一种基于环糊精-金刚烷化铱络合物主客体组装标记的蛋白标记物荧光检测方法
CN118311253A (zh) * 2023-01-09 2024-07-09 广州达安基因股份有限公司 检测新型冠状病毒的检测卡的制备方法及检测卡
CN120741863B (zh) * 2025-06-06 2026-01-06 上海太阳生物技术有限公司 蛋白c检测试剂

Family Cites Families (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704366A (en) 1984-06-22 1987-11-03 Bio-Rad Laboratories, Inc. Process for binding IgG to protein A
US5186844A (en) 1991-04-01 1993-02-16 Abaxis, Inc. Apparatus and method for continuous centrifugal blood cell separation
US5122284A (en) 1990-06-04 1992-06-16 Abaxis, Inc. Apparatus and method for optically analyzing biological fluids
US5061381A (en) 1990-06-04 1991-10-29 Abaxis, Inc. Apparatus and method for separating cells from biological fluids
US5413732A (en) 1991-08-19 1995-05-09 Abaxis, Inc. Reagent compositions for analytical testing
US5304348A (en) 1992-02-11 1994-04-19 Abaxis, Inc. Reagent container for analytical rotor
AU4047493A (en) 1992-04-02 1993-11-08 Abaxis, Inc. Analytical rotor with dye mixing chamber
JP3706214B2 (ja) 1996-10-28 2005-10-12 株式会社三菱化学ヤトロン 免疫学的分析方法
US5939021A (en) 1997-01-23 1999-08-17 Hansen; W. Peter Homogeneous binding assay
US6180415B1 (en) 1997-02-20 2001-01-30 The Regents Of The University Of California Plasmon resonant particles, methods and apparatus
US6344272B1 (en) 1997-03-12 2002-02-05 Wm. Marsh Rice University Metal nanoshells
US7144627B2 (en) 1997-03-12 2006-12-05 William Marsh Rice University Multi-layer nanoshells comprising a metallic or conducting shell
JPH10282100A (ja) * 1997-04-11 1998-10-23 Sekisui Chem Co Ltd 測定方法及び測定キット
ATE417275T1 (de) * 1997-09-22 2008-12-15 Novartis Vaccines & Diagnostic Puffern zur stabilizierung von hcv antigenen
US6699724B1 (en) 1998-03-11 2004-03-02 Wm. Marsh Rice University Metal nanoshells for biosensing applications
JP3841559B2 (ja) 1998-07-07 2006-11-01 日東電工株式会社 免疫学的検査方法および免疫学的検査キット
JP2000028612A (ja) 1998-07-07 2000-01-28 Nitto Denko Corp 免疫学的検査方法および免疫学的検査キット
JP3298836B2 (ja) 1998-11-12 2002-07-08 アークレイ株式会社 検体分析用具
US6579726B1 (en) 1999-07-30 2003-06-17 Surromed, Inc. Instruments, methods and reagents for surface plasmon resonance
JP2001074742A (ja) * 1999-09-06 2001-03-23 Jsr Corp ラテックス免疫比濁法および測定キット
EP1236034A4 (en) 1999-11-12 2006-05-03 Surromed Inc PLASMON RESONANCE SURFACE BIODETECTION
WO2002079764A1 (en) 2001-01-26 2002-10-10 Nanoplex Technologies, Inc. Surface-enhanced spectroscopy-active sandwich nanoparticles
WO2002059226A2 (en) 2000-11-03 2002-08-01 Wm. Marsh Rice University Partial coverage metal nanoshells and method of making same
US20030170618A1 (en) 2001-02-02 2003-09-11 Chien David Y. Buffers for stabilizing antigens
US7238472B2 (en) 2001-05-25 2007-07-03 Nanosphere, Inc. Non-alloying core shell nanoparticles
US20050037437A1 (en) 2001-09-14 2005-02-17 Reinhard Zeidler Identification of antigen by xenogenic, allogenic or autologous antibody-mediated precipitation
US7135054B2 (en) 2001-09-26 2006-11-14 Northwestern University Nanoprisms and method of making them
CN1417586A (zh) 2001-11-05 2003-05-14 福州市迈新生物技术开发公司 一种免疫检测信号放大系统和它的制备方法及其应用
JP3851807B2 (ja) 2001-11-07 2006-11-29 アルフレッサファーマ株式会社 免疫反応におけるプロゾーン現象抑制方法及び免疫反応測定用試薬
US6970239B2 (en) 2002-06-12 2005-11-29 Intel Corporation Metal coated nanocrystalline silicon as an active surface enhanced Raman spectroscopy (SERS) substrate
US7212692B2 (en) 2002-11-08 2007-05-01 Ming Yan Multiple array surface plasmon resonance biosensor
KR20050083623A (ko) * 2002-12-10 2005-08-26 마쯔시다덴기산교 가부시키가이샤 면역반응 측정방법
JP4787938B2 (ja) 2003-03-28 2011-10-05 ザ・プロウボウスト・フェロウズ・ファウンデーション・スカラーズ・アンド・ザ・アザー・メンバーズ・オブ・ボード・オブ・ザ・カレッジ・オブ・ザ・ホリー・アンド・アンデバイデッド・トリニティ・オブ・クイーン 銀ナノ粒子を用いた検体検出用センサ
KR100531760B1 (ko) 2003-04-28 2005-11-29 대한민국(관리부서 : 농림부 국립수의과학검역원) 구제역 바이러스의 감염여부를 진단하는 방법 및 이를구현하기 위한 진단키트
US20060240573A1 (en) 2003-07-29 2006-10-26 Lamdagen, Llc Optical system including nanostructures for biological or chemical sensing
GB0321937D0 (en) 2003-09-19 2003-10-22 Univ Liverpool Nanoparticle conjugates and method of production thereof
EP1692514A4 (en) 2003-11-07 2008-04-09 Hepgenics Pty Ltd BINDING ASSAY COMPONENTS
JP4109205B2 (ja) 2004-01-07 2008-07-02 富士フイルム株式会社 被検体検出方法
EP1836495A2 (en) 2004-11-17 2007-09-26 BioVeris Corporation Electrochemiluminescent assay
CN1296492C (zh) 2004-11-18 2007-01-24 博奥生物有限公司 一种基于生物芯片检测能结合特异序列的核酸结合蛋白的方法
US7405054B1 (en) 2004-12-13 2008-07-29 University Of Washington Uw Tech Transfer - Invention Licensing Signal amplification method for surface plasmon resonance-based chemical detection
US20060172357A1 (en) 2004-12-31 2006-08-03 Genentech Detecting human antibodies in non-human serum
US8628727B2 (en) 2005-04-08 2014-01-14 Northwestern University Compositions, devices and methods for SERS and LSPR
US20060246513A1 (en) 2005-05-02 2006-11-02 Bohannon Robert C Method and device to detect the presence of analytes in a sample
EP1915610A4 (en) 2005-06-15 2010-05-19 Univ Maryland Biotech Inst BIOASSAYS WITH PLASMONIC SPREADING OF PRECIOUS METAL NANOSTRUCTURES
US20070092978A1 (en) 2005-10-20 2007-04-26 Ronald Mink Target ligand detection
JP5442179B2 (ja) 2005-10-21 2014-03-12 アルフレッサファーマ株式会社 反応性物質が結合した微小粒子の沈降抑制方法および該微小粒子含有試薬
CA2627376C (en) 2005-10-25 2016-07-05 Donald Templeton Haynie Immunogenic compositions and methods of use
US7888043B2 (en) 2005-11-18 2011-02-15 The United States Of America As Represented By The Department Of Health And Human Services, Centers For Disease Control And Prevention Modified cardiolipin and uses therefor
WO2007103802A2 (en) 2006-03-03 2007-09-13 William Marsh Rice University Nanorice particles: hybrid plasmonic nanostructures
JP4810304B2 (ja) 2006-05-12 2011-11-09 キヤノン株式会社 化学センサ素子及びその製造方法
JP2010533281A (ja) 2006-06-06 2010-10-21 ビバクタ、リミテッド 化学物質の検知方法
JP2008157652A (ja) 2006-12-21 2008-07-10 Yokogawa Electric Corp 電源装置
US8426152B2 (en) 2007-01-03 2013-04-23 Lamdagen Corporation Enzymatic assay for LSPR
ES2635272T3 (es) 2007-03-20 2017-10-03 Becton, Dickinson And Company Ensayo que usa partículas activas en espectroscopia Raman potenciada en superficie (SERS)
JP2009150708A (ja) 2007-12-19 2009-07-09 Canon Inc 標的物質の検出方法及び検査キット
US8808420B2 (en) 2007-12-21 2014-08-19 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Process for preparing nanoparticles
JP2011508062A (ja) * 2007-12-28 2011-03-10 スリーエム イノベイティブ プロパティズ カンパニー 可撓性封入フィルムシステム
US8137920B2 (en) 2008-03-20 2012-03-20 Abaxis, Inc. Multi-wavelength analyses of sol-particle specific binding assays
WO2010006201A2 (en) 2008-07-10 2010-01-14 Abaxis, Inc. Methods of reducing non-specific interaction in metal nanoparticle assays
US8846319B2 (en) 2008-12-03 2014-09-30 Abaxis, Inc. Lateral flow strip assay with immobilized conjugate
US8313915B2 (en) 2009-01-21 2012-11-20 Gundersen Lutheran Medical Foundation, Inc. Early detection of canine lyme disease by specific peptides and antibodies
WO2010091293A1 (en) 2009-02-06 2010-08-12 The Regents Of The University Of California Plasmonic system for detecting binding of biological molecules
CA2753598C (en) 2009-02-27 2018-07-10 Beckman Coulter, Inc. Solution phase homogeneous assays
WO2010116346A1 (en) 2009-04-08 2010-10-14 National University Of Ireland, Galway Silver nanoplates
JP5563789B2 (ja) 2009-06-11 2014-07-30 富士フイルム株式会社 検出方法
US9274125B2 (en) 2009-10-30 2016-03-01 Kyowa Medex Co., Ltd. Method and kit for measuring component in the presence of fatty acid alkanolamide or nonionic polyoxyethylene surfactant
AU2010322085B2 (en) 2009-11-17 2016-09-15 Zoetis Services Llc Peptides and methods for the detection of Lyme disease antibodies
JP6161291B2 (ja) 2009-11-20 2017-07-12 アバクシス, インコーポレイテッド エールリッヒア抗体の検出のためのペプチド、装置、および方法
WO2011065747A2 (ko) 2009-11-24 2011-06-03 한국생명공학연구원 나노입자를 이용한 미생물의 고속 검출방법
US9308582B2 (en) 2009-12-24 2016-04-12 Yi Sun Solution stable and chemically reactive metallic nanoparticles
EP2354792A1 (en) 2010-02-08 2011-08-10 Biomonitor A/S Method for detecting anti-drug antibodies
DK2564203T3 (en) 2010-04-27 2017-08-21 Ventana Med Syst Inc Antibody-nanoparticle conjugates and methods for preparing and using such conjugates
US20130071619A1 (en) 2010-05-28 2013-03-21 Nippon Steel & Sumikin Chemical Co., Ltd. Metal fine-particle composite and method for fabricating the same
CN102023151B (zh) 2010-09-17 2013-01-02 江南大学 用拉曼光谱在金纳米棒端面自组装介导下检测微囊藻毒素的方法
WO2012077756A1 (ja) 2010-12-08 2012-06-14 公立大学法人大阪府立大学 金属ナノ粒子集積構造体を利用した被検出物質の検出装置および方法
JP5614278B2 (ja) 2010-12-24 2014-10-29 セイコーエプソン株式会社 センサーチップ、センサーチップの製造方法、検出装置
CN102103145B (zh) 2011-02-24 2013-01-16 南京基蛋生物科技有限公司 一种双放大系统的胶体金试纸条及其制备方法
US8697129B2 (en) 2011-03-02 2014-04-15 Imra America, Inc. Stable colloidal gold nanoparticles with controllable surface modification and functionalization
WO2012125693A2 (en) 2011-03-15 2012-09-20 Northwestern University Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same
JP5703098B2 (ja) 2011-03-31 2015-04-15 富士フイルム株式会社 生体分子検出装置および生体分子検出方法
CN102323422B (zh) * 2011-05-30 2014-03-12 中国科学院上海微系统与信息技术研究所 半定量同时检测cTnI和Myo的免疫层析试纸条及其制备
US20130230717A1 (en) 2011-09-02 2013-09-05 Washington University In St. Louis Copper nanostructures and methods for their preparation
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
CH705758B1 (fr) 2011-11-15 2016-03-31 Metalor Technologies Int Nanoparticules cœur-coquille métal-silice, procédé de fabrication et dispositif de test par immunochromatographie comprenant de telles nanoparticules.
PT3489685T (pt) 2011-11-21 2024-01-04 Zoetis Services Llc Amplificação de sinais em imunoensaios de fluxo lateral e relacionados
US9823246B2 (en) 2011-12-28 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Fluorescence enhancing plasmonic nanoscopic gold films and assays based thereon
US20130189793A1 (en) 2012-01-20 2013-07-25 Wei Qian Stable Colloidal Suspensions Of Gold Nanoconjugates And The Method For Preparing The Same
US20150017258A1 (en) 2012-01-31 2015-01-15 American University Of Cairo (Auc) Direct detection of disease biomarkers in clinical specimens using cationic nanoparticle-based assays & versatile and green methods for synthesis of anisotropic silver nanostructures
EP2625966A1 (en) 2012-02-13 2013-08-14 Bionanoplus, S.L. Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof
TWI435843B (zh) 2012-04-27 2014-05-01 Univ Nat Taiwan 奈米顆粒的製造方法
WO2013169640A1 (en) 2012-05-05 2013-11-14 Academia Sinica Diaminobenzoic or ortho-phenylene diamine conjugated peptides as functional saccharide tagging reagents
WO2014020293A1 (en) * 2012-07-31 2014-02-06 Imperial Innovations Limited Assay
BR112015008036B1 (pt) 2012-10-11 2022-09-13 Zoetis Services Llc População de peptídeos isolados, método para detectar em uma amostra um anticorpo, método para diagnosticar erliquiose monocítica e/ou granulocítica, método para detectar a presença de anticorpos e kit
CA2887687A1 (en) 2012-10-11 2014-04-17 Nanocomposix, Inc. Silver nanoplate compositions and methods
US9441301B2 (en) 2012-12-06 2016-09-13 Nanyang Technological University Method for forming a bimetallic core-shell nanostructure
EP2963419A4 (en) 2013-03-01 2016-11-02 Fujirebio Kk METHOD FOR PREVENTING THE DECOMPOSITION OF AN UNSENSIBILIZED LATEX REAGENT
JP2016512241A (ja) * 2013-03-14 2016-04-25 アボット・ラボラトリーズAbbott Laboratories 改良された抗体検出のためのhcvns3組換え抗原およびこの突然変異体
BR112015023239A8 (pt) * 2013-03-14 2018-04-17 Abbott Lab ensaio de combinação de anticorpo-antígeno de hcv e métodos e composições para uso do mesmo
FR3003353B1 (fr) 2013-03-14 2015-03-06 Horiba Abx Sas Nouvelle methode de dosage en flux d'un objet d'interet
JP2014228385A (ja) 2013-05-22 2014-12-08 キヤノン株式会社 免疫試験方法および免疫試験キット
US20160120978A1 (en) 2013-06-05 2016-05-05 Purdue Research Foundation Titanium nitride plasmonic nanoparticles for clinical therapeutic applications
CN103335984B (zh) 2013-06-09 2015-10-28 清华大学 一种基于lspr的无实体壁微阵列芯片及其应用
CN105393119A (zh) 2013-07-30 2016-03-09 生物辐射实验室股份有限公司 用于免疫试验的多重封闭物珠
KR20160138059A (ko) 2014-02-26 2016-12-02 람다젠 코퍼레이션 향상된 검정 감도를 위한 디지털 lspr
US10024800B2 (en) 2014-04-15 2018-07-17 Rutgers, The State University Of New Jersey Gold nanostar substrates for SERS sensing in the femtomolar regime
US10518331B2 (en) 2014-07-11 2019-12-31 Northwestern University Synthesis of uniform anisotropic nanoparticles
CN105492605A (zh) 2014-08-01 2016-04-13 比科尔公司 用于免疫检验的病毒样颗粒、用于所述免疫检验的封闭剂、及包含它们的试剂盒
TWI691716B (zh) 2014-08-13 2020-04-21 美商艾巴希斯公司 電漿特異性結合搭配物檢定中之信號放大
CA2976963A1 (en) 2015-02-19 2016-08-25 Ionica Sciences Reagents and methods for detecting infectious diseases
WO2016170183A1 (en) 2015-04-24 2016-10-27 Pharmadiagnostics Nv Improved method of measuring an interaction between molecules
EP4465021A3 (en) 2015-08-04 2025-02-26 Zoetis Services LLC Signal amplification in solution-based plasmonic specific-binding partner assays
CN106290893B (zh) 2016-07-18 2018-09-25 南昌大学 一种基于纳米铂探针检测牛乳β-乳球蛋白及其致敏性残基的方法
WO2018140953A1 (en) 2017-01-30 2018-08-02 Abaxis, Inc. Solution-based plasmon specific-binding partner assays and metallic nanostructures

Also Published As

Publication number Publication date
AU2022246447B2 (en) 2024-12-19
US20220091113A1 (en) 2022-03-24
KR102897521B1 (ko) 2025-12-09
KR102654470B1 (ko) 2024-04-05
WO2018140953A1 (en) 2018-08-02
IL268238B (en) 2022-09-01
AU2022246447A1 (en) 2022-11-03
EP3574308A1 (en) 2019-12-04
JP7308148B2 (ja) 2023-07-13
CN120446063A (zh) 2025-08-08
MX2023002376A (es) 2023-03-23
CN118275398A (zh) 2024-07-02
JP2020509349A (ja) 2020-03-26
US11977072B2 (en) 2024-05-07
IL295118A (en) 2022-09-01
CN110892250A (zh) 2020-03-17
KR20190112783A (ko) 2019-10-07
BR112019015664A2 (pt) 2020-03-31
US20250044286A1 (en) 2025-02-06
KR20230011477A (ko) 2023-01-20
AU2018212009A1 (en) 2019-08-15
EP3574308A4 (en) 2020-12-30
AU2018212009B2 (en) 2022-07-14
IL268238A (en) 2019-09-26
MX2023012379A (es) 2023-11-01
NZ796662A (en) 2026-03-27
IL295118B2 (en) 2025-06-01
IL295118B1 (en) 2025-02-01
NZ755886A (en) 2023-09-29
JP2023099008A (ja) 2023-07-11
KR102486615B1 (ko) 2023-01-11
CA3051465A1 (en) 2018-08-02
KR20240039224A (ko) 2024-03-26

Similar Documents

Publication Publication Date Title
MX2023002376A (es) Ensayos de socio de union especifico de plasmon basados en solucion y nanoestructuras metalicas.
CY1124717T1 (el) Μεθοδοι, kit και συσκευη για επεκταση πληθυσμου κυτταρων
MX362075B (es) Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
CO2019012771A2 (es) Ensayos de diagnóstico para detectar, cuantificar y/o rastrear microbios y otros analitos
ES2509894T3 (es) Métodos, dispositivos, kits y composiciones para detectar gusano redondo, gusano látigo y gusano de gancho
MX2017015011A (es) Ensayo a base de celulas para detectar homodimeros anti-cd3.
ECSP088081A (es) Detección de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapéutico correspondiente
BR112015022490A2 (pt) métodos e composições para classificação de amostras
MX2020004921A (es) Ensayo de anticuerpo antifarmaco con supresion de interferencia del objetivo.
BR112016007106A2 (pt) dispositivo e método de teste de gravidez melhorado
MX2016011809A (es) Inmunoensayo de canalización de oxígeno luminiscente utilizando tres anticuerpos y metodos de produccion y uso de los mismos.
MX2022013567A (es) Amplificacion de se?al en ensayos de compa?ero de union especifico de plasmones.
EA201390638A1 (ru) Обогащение и идентификация фетальных клеток в материнской крови и лиганды для такого применения
CO2019002607A2 (es) Biomarcadores de metabolitos para enfermedades asociadas con el sistema de activación por contacto
BR112014032916A2 (pt) anticorpos anti-fármacos e usos destes para o monitoramento de fármaco
EP4465021A3 (en) Signal amplification in solution-based plasmonic specific-binding partner assays
MX2020003523A (es) Deteccion de dimetilarginina simetrica.
WO2015176162A8 (en) Methods for determining lymphocyte receptor chain pairs
BR112018007842A2 (pt) imunoensaio para a detecção de cininogênio clivado de alto peso molecular, método, anticorpo isolado, kit para detectar um cininogênio de alto peso molecular clivado (hmwk)
MX383423B (es) Método in vitro para el diagnóstico del síndrqme del intestino irritable y la enfermedad inflamatoria intestinal.
MX2019002929A (es) Biomarcadores de arn para angioedema hereditario.
MX2017001134A (es) Composiciones y metodos para la deteccion y analisis de tuberculosis micobacteriana.
RU2016145600A (ru) Комбинированный продукт для детекции маркера-мишени
CL2008001621A1 (es) Metodo para detectar el componente caliqueamicina en un conjugado covalente caliqueamicina-portador en una muestra de fluido, donde la caliqueamicina se detecta luego de romper dicha union, preferentemente por espectrometria de masas; kit para determinar la concentracion de caliqueamicina en una muestra.
MX2020002395A (es) Metodos para evaluar conjugados de anticuerpos y farmacos.